These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1851015)

  • 1. Opiate agonists activate feeding in Limax: comparison of in vivo and in vitro effects.
    Wong M; Delaney K; Gelperin A
    Behav Neurosci; 1991 Feb; 105(1):15-24. PubMed ID: 1851015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu- and kappa-opiate agonists modulate ingestive behaviors in the slug, Limax maximus.
    Kavaliers M; Rangeley RW; Hirst M; Teskey GC
    Pharmacol Biochem Behav; 1986 Mar; 24(3):561-6. PubMed ID: 3010335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential opiate influences on food hoarding and intake in the deer mouse, Peromyscus maniculatus.
    Kavaliers M; Hirst M
    Life Sci; 1985 Dec; 37(23):2213-20. PubMed ID: 2999543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory activity of mu- and kappa-selective opioid agonists.
    Taub DD; Eisenstein TK; Geller EB; Adler MW; Rogers TJ
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):360-4. PubMed ID: 1846441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
    Millan MJ; Członkowski A; Lipkowski A; Herz A
    J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.
    Millan MJ; Morris BJ; Herz A
    J Pharmacol Exp Ther; 1988 Nov; 247(2):721-8. PubMed ID: 2846827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic systemic administration of amphetamine increases food intake to morphine, but not to U50-488H, microinjected into the ventral tegmental area in rats.
    Nencini P; Stewart J
    Brain Res; 1990 Sep; 527(2):254-8. PubMed ID: 2174718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Food hoarding and ingestion in the deer mouse, Peromyscus maniculatus: selective responses to mu and kappa opiate agonists.
    Kavaliers M; Hirst M
    Pharmacol Biochem Behav; 1986 Sep; 25(3):543-8. PubMed ID: 3022306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
    Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intracerebroventricularly administered mu-, delta- and kappa-opioid agonists on locomotor activity of the guinea pig and the pharmacology of the locomotor response to U50,488H.
    Bot G; Chahl LA; Brent PJ; Johnston PA
    Neuropharmacology; 1992 Sep; 31(9):825-33. PubMed ID: 1359440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sufentanil, morphine, met-enkephalin, and kappa-agonist (U-50,488H) inhibit substance P release from primary sensory neurons: a model for presynaptic spinal opioid actions.
    Chang HM; Berde CB; Holz GG; Steward GF; Kream RM
    Anesthesiology; 1989 Apr; 70(4):672-7. PubMed ID: 2467589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential cross-tolerance to mu and kappa opioid agonists in morphine-tolerant rats responding under a schedule of food presentation.
    Picker MJ; Negus SS; Powell KR
    Psychopharmacology (Berl); 1991; 103(1):129-35. PubMed ID: 1848712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FMRFamide suppresses kappa opiate induced feeding in the mouse.
    Kavaliers M; Hirst M
    Peptides; 1985; 6(5):847-9. PubMed ID: 3001666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats.
    Herrero JF; Headley PM
    Br J Pharmacol; 1991 Sep; 104(1):166-70. PubMed ID: 1664760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U50,488H differentially antagonizes the bladder effects of mu agonists at spinal sites.
    Sheldon RJ; Nunan L; Porreca F
    Eur J Pharmacol; 1988 Feb; 146(2-3):229-35. PubMed ID: 2836207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opiatergic modulation of preparatory and consummatory components of feeding and drinking.
    Nencini P; Graziani M
    Pharmacol Biochem Behav; 1990 Nov; 37(3):531-7. PubMed ID: 1965043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice.
    Kuzmin AV; Semenova S; Gerrits MA; Zvartau EE; Van Ree JM
    Eur J Pharmacol; 1997 Mar; 321(3):265-71. PubMed ID: 9085036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.